NP-101020 derivatives (Noscira)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNP-101020 derivatives (Noscira)
Drug Alias NameGSK-3 inhibitors (Noscira)glycogen synthase kinase 3 inhibitors (Noscira)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 degraders
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNoscira Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNoscira Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A